1, usage and dosage
It should be taken within 72 hours to prevent rejection of dose transplantation. 1 twice a day is safer than 1 three times a day. Refractory rejection should be 1.5g twice a day. If the patient has neutropenia during taking the medicine, the drug should be stopped immediately or the dose should be reduced.
2. Side effects
Although drugs can effectively prevent rejection, there are still some adverse reactions when using drugs. Some patients will have symptoms such as anemia, nausea, diarrhea and indigestion after taking the medicine. These are some common adverse reactions and symptoms. If these phenomena occur during the medication, the patient should stop taking the drug immediately.
As an immunosuppressant, it has certain toxicity. If taken for a long time, patients are prone to vomiting and diarrhea, and the number of white blood cells in the body is reduced. What needs to be paid great attention to is that long-term use of this drug will also increase the incidence of lymphoma and malignant tumor. In order to prevent skin cancer, patients should basically wear protective clothing or sunscreen when going out during medication to reduce the influence of sunlight and ultraviolet rays. Therefore, the side effects of mycophenolate mofetil capsules are great.
3. Pay attention to medication
In general, mycophenolate mofetil capsules need to be taken on an empty stomach, which can make the drug's efficacy play better and achieve the best treatment state. If you can't take the medicine on time before meals, you can also take mycophenolate mofetil capsules about an hour after meals. During taking the medicine, mention the precautions of mycophenolate mofetil capsules. Patients need to know that this drug cannot be absorbed by patients through rapid intravenous injection. In addition, because patients are at risk of skin diseases, we should reduce the exposure to the sun when using drugs.
Not only that, patients should go to the hospital for examination, diagnosis and treatment in time when there are adverse reactions such as accidental abrasions and bleeding, so as to avoid aggravation. If the patient has allergic reaction to any component of the drug, the drug should be banned to avoid increasing the probability of side effects.
4. Function indication
Mycophenolate mofetil capsules can rapidly differentiate into MPA in vivo after oral administration, and MPA can specifically inhibit the activity of hypoxanthine nucleotide dehydroacid (1MPDH) in the pathway of purine de novo synthesis in lymphocytes, so it has a strong inhibitory effect on lymphocyte proliferation, especially on B lymphocyte transformation induced by EB virus, but it has a weak inhibitory effect on other rapidly dividing cells.
Clinically, mycophenolate mofetil capsules are mainly used for kidney and heart transplant patients. Mycophenolate mofetil can maintain immunosuppression and be used as an alternative therapy for patients with severe nephrotoxicity and hemolytic uremic syndrome after transplantation. It can also be used to treat autoimmune diseases, such as pemphigus, bullous pemphigoid, systemic lupus erythematosus (SLE), psoriasis, etc. Its therapeutic effect is quite remarkable.
Mortimer's mycophenolate mofetil capsules are prescription drugs. Prescription drugs refer to drugs prescribed by doctors with prescription rights and purchased from hospital pharmacies.
As we all know, if organ transplantation is carried out, there will be rejection between xenografts. This refusal will cause physical discomfort, but it will endanger life safety. Drug mycophenolate mofetil capsule is a preventive drug to prevent rejection during organ transplantation.